Literature DB >> 24777673

Pulmonic regurgitation and management challenges in the adult with tetralogy of fallot.

Emily Ruckdeschel1, Joseph D Kay.   

Abstract

OPINION STATEMENT: Patients with tetralogy of Fallot (TOF) are living longer than ever because of advances in surgery in childhood since the 1950s. However, surgery in childhood is not a cure and remains only a palliative procedure because almost all patients will require further intervention throughout life. The most common intervention required in adulthood is pulmonary valve replacement (PVR) because of residual pulmonary regurgitation leading to right ventricular dilation and eventual dysfunction. The most appropriate timing for PVR remains difficult to determine and is based on many factors. Our practice is to weigh not only objective factors such as right ventricular size and function but also careful objective assessment of the patient's current quality of life and functional status.

Entities:  

Year:  2014        PMID: 24777673     DOI: 10.1007/s11936-014-0314-5

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  55 in total

1.  Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair.

Authors:  Judith Therrien; Yves Provost; Naeem Merchant; William Williams; Jack Colman; Gary Webb
Journal:  Am J Cardiol       Date:  2005-03-15       Impact factor: 2.778

2.  Long-term results after early primary repair of tetralogy of Fallot.

Authors:  E A Bacha; A M Scheule; D Zurakowski; L C Erickson; J Hung; P Lang; J E Mayer; P J del Nido; R A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2001-07       Impact factor: 5.209

3.  Pulmonary valve replacement long after repair of tetralogy of Fallot.

Authors:  Yuichi Shiokawa; Hiromichi Sonoda; Yoshihisa Tanoue; Takahiro Nishida; Atsuhiro Nakashima; Ryuji Tominaga
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-08

4.  Multicenter research in adult congenital heart disease.

Authors:  Paul Khairy; Jamil Aboul Hosn; Craig Broberg; Stephen Cook; Michael Earing; Deborah Gersony; Joseph Kay; Michael J Landzberg; Michelle J Nickolaus; Sasha Opotowsky; Anne Marie Valente; Carole Warnes; Gary Webb; Michelle Z Gurvitz
Journal:  Int J Cardiol       Date:  2008-06-24       Impact factor: 4.164

Review 5.  Aortic root dilatation in tetralogy of Fallot long-term after repair--histology of the aorta in tetralogy of Fallot: evidence of intrinsic aortopathy.

Authors:  Koichiro Niwa
Journal:  Int J Cardiol       Date:  2005-08-18       Impact factor: 4.164

6.  Homograft insertion for pulmonary regurgitation after repair of tetralogy of fallot improves cardiorespiratory exercise performance.

Authors:  B Eyskens; T Reybrouck; J Bogaert; S Dymarkowsky; W Daenen; M Dumoulin; M Gewillig
Journal:  Am J Cardiol       Date:  2000-01-15       Impact factor: 2.778

7.  Percutaneous insertion of the pulmonary valve.

Authors:  Philipp Bonhoeffer; Younes Boudjemline; Shakeel A Qureshi; Jerome Le Bidois; Laurence Iserin; Philippe Acar; Jacques Merckx; Jean Kachaner; Daniel Sidi
Journal:  J Am Coll Cardiol       Date:  2002-05-15       Impact factor: 24.094

8.  Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot.

Authors:  Gerhard-Paul Diller; Aleksander Kempny; Emmanouil Liodakis; Rafael Alonso-Gonzalez; Ryo Inuzuka; Anselm Uebing; Stefan Orwat; Konstantinos Dimopoulos; Lorna Swan; Wei Li; Michael A Gatzoulis; Helmut Baumgartner
Journal:  Circulation       Date:  2012-04-11       Impact factor: 29.690

9.  Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients.

Authors:  Sachin Khambadkone; Louise Coats; Andrew Taylor; Younes Boudjemline; Graham Derrick; Victor Tsang; Jeffrey Cooper; Vivek Muthurangu; Sanjeet R Hegde; Reza S Razavi; Denis Pellerin; John Deanfield; Philipp Bonhoeffer
Journal:  Circulation       Date:  2005-08-15       Impact factor: 29.690

10.  Outcomes of pregnancy in women with tetralogy of Fallot.

Authors:  Gruschen R Veldtman; Heidi M Connolly; Martha Grogan; Naser M Ammash; Carole A Warnes
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.